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Abstract 
Focused ultrasound and microbubbles have been extensively used to generate therapeutic 
bioeffects. Despite encouraging in vivo results, there remains poor control of the 
magnitude and spatial distribution of these bioeffects due to the limited ability of 
conventional pulse shapes and sequences to control cavitation dynamics. Thus current 5 
techniques are restricted by an efficacy-safety trade-off. The primary aim of the present 
study was to incorporate the presence of flow in the design of new short pulse sequences, 
which can more uniformly distribute the cavitation activity. Microbubbles flowing 
(fluid velocity: 10mm/s) through a 300 μm tube were sonicated with a focused 
0.5MHz transducer while acoustic emissions were captured with an insert focused 10 
7.5MHz passive cavitation detector, with the two foci being co-axially aligned and 
overlapped. Whereas conventional sequences are composed of a long burst (>10,000 
cycles) emitted at a low burst repetition frequency (<10 Hz), we decomposed this burst 
into short pulses by adding intervals to facilitate inter-pulse microbubble movement. To 
evaluate how this sequence influenced cavitation distribution, we emitted short pulses 15 
(peak-rarefactional pressure (PRP): 40-366kPa, pulse length (PL): 5-25 cycles) at high 
pulse repetition frequencies (PRF: 0.625-10kHz) for a burst length of 100ms. Increased 
cavitation persistence, implied by the duration of the microbubble acoustic emissions, 
was a measure of improved distribution due to the presence of flow. Sonication at lower 
acoustic pressures, longer pulse intervals and lower PLs improved the spatial distribution 20 
of cavitation. Furthermore, spectral analysis of the microbubble emissions revealed that 
the improvement at low pressures is due to persisting stable cavitation. In conclusion, 
new short-pulse sequences were shown to improve spatiotemporal control of acoustic 
cavitation dynamics during physiologically relevant flow. This could lead to adjustable 
distribution of the generated in vivo bioeffect and therefore efficient and safe treatment 25 
of a wide range of pathologies.  
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1. Introduction 
Recent advances in ultrasound therapy involve the use of focused ultrasound (FUS) and 
systemically administered microbubbles (MBs) (Stride and Coussios 2010) for a range of 
therapeutic applications such as targeted drug delivery (Ferrara et al 2007), sonothrombolysis 
(de Saint Victor et al 2014), sonoporation (Yu and Xu 2014), renal ultrafiltration (Deelman et 5 
al 2010) and blood-brain barrier opening (Konofagou 2012). FUS has the advantage of 
penetrating deep into the body and localising its interaction with MBs within a well-defined 
target region, i.e. the focal volume. MBs, which are typically composed of a gas-core and a 
lipid-shell, can be driven into radial oscillations by the rarefactional and compressional 
phases of the acoustic wave (Apfel 1997). This acoustically driven behaviour, known as 10 
acoustic cavitation, has been shown capable of producing either therapeutic or harmful 
bioeffects. Thus, understanding how cavitation dynamics are dictated by ultrasound 
parameters and designing new pulse shapes and sequences to produce new dynamics could 
improve therapeutic and safety outcomes. 
Specific characteristics of an ultrasonic pulse shape (i.e. centre frequency, pulse length (PL), 15 
and peak-rarefactional pressure (PRP)) and sequence (i.e. pulse repetition frequency (PRF)) 
have been shown to dictate specific types and magnitudes of cavitation. The centre 
frequency influences the frequency that MBs radially oscillate, with the oscillation 
amplitude being the greatest for MBs of resonant size at low acoustic pressures 
(Marmottant et al 2005, Apfel and Holland 1991, Lauterborn 1976). The PRP determines the 20 
amplitude of radial oscillation while the PL matches with the cavitation duration. PLs also 
influence the primary radiation force (Dayton et al 2002, 1997); long pulses push the MBs 
across a greater length, because the force is applied over a longer duration (Palanchon et al 
2005). Modification of these three pulse shape features can produce a range of cavitation 
behaviours from low-amplitude non-inertial cavitation to high-amplitude inertial cavitation, 25 
in which MBs expand and collapse violently due to the inertia of the surrounding fluid (Apfel 
1997). Pulse shapes trigger cavitation dynamics on a time scale of microseconds and 
therefore interact with a single population of MBs. In therapeutic ultrasound, a large portion 
of the MBs are destroyed or modified by the end of the pulse and thus a pulse-off-time is 
required to allow new MBs to replenish the target volume. Conventional therapeutic pulse 30 
sequences thus employ a pulse repetition frequency (PRF) typically on the order of Hz and a 
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defined number of pulses, which determines the number of cavitation events the tissue is 
treated by and the duration of the treatment. 
Depending on the ultrasonic pulse shape and the properties of the fluid surrounding the MBs, 
ultrasound exposure can cause the MBs to radially oscillate in either linear or non-linear 
cavitation modes: stable and non-inertial, stable and inertial, or transient and inertial 5 
cavitation (Church and Carstensen 2001). Cavitation modes can be identified by analysing 
the acoustic emissions from the MBs. High magnitude non-inertial and low magnitude 
inertial cavitation events radiate acoustic emissions at the driving ultrasound frequency and 
its integer multiples or harmonics (Apfel 1997). In contrast, high magnitude inertial 
cavitation, which is created by the unstable expansion and subsequent violent MB collapse 10 
(Chomas et al 2001) yields broadband acoustic emissions. Spectral analysis of the acoustic 
emissions can thus identify distinct cavitation dynamics. 
Inertial and non-inertial cavitation modes have been shown to cause bioeffects by exerting 
mechanical forces on biological interfaces, such as the vascular wall or the cell membrane. 
Theoretical and experimental approaches have characterized MB-vessel interactions 15 
according to the mechanical stress exerted on the vascular wall and have correlated these 
measurements to vascular damage (Hosseinkhah et al 2013, Hosseinkhah and Hynynen 2012, 
Chen et al 2012, Caskey et al 2007, Qin and Ferrara 2006). Bubble collapse was shown to 
exert up to four times higher stress than stable bubble expansion (Hosseinkhah et al 2013). 
Optical evidence suggested that the stress caused by stable cavitation originates from the 20 
direct contact between the oscillating MBs and the endothelium of small vessels (Caskey et al 
2007). Although the exact mechanisms remain unclear, MB-mediated mechanical agitation of 
the vasculature has been shown to alter capillary permeability in the brain (Hynynen et al 
2001), kidney (Li et al 2013, Fischer et al 2009), liver (Wang et al 2013), prostate (Liu et al 
2013) and other organs. The advantage of these capillary opening techniques is that they can 25 
noninvasively and locally increase the delivered concentration of drugs to a target tissue, thus 
reducing the required systemic doses and thereby minimizing deleterious side-effects. Drug 
delivery is particularly limited in the brain due to the blood-brain barrier (BBB) which tightly 
separates the vessel lumen from the brain interstitial space (Zlokovic 2008). 
Neurodegenerative diseases like Alzheimer’s, Parkinson syndrome and multiple sclerosis 30 
remain untreatable partly because of the impermeability of the BBB to large therapeutic 
molecules such as antibodies or peptides (Konofagou 2012). For this reason, a large body of 
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work has focused on the disruption of BBB using the FUS-MBs system (Wang et al 2014, 
Nhan et al 2013, Vlachos et al 2011, Choi et al 2011b, Tung et al 2010). Yet it has been 
previously shown that conventional pulse shapes and sequences are limited by an efficacy-
safety trade-off. Higher pressures increased doses delivered (Baseri et al 2010), but they were 
also associated with cell necrosis or erythrocyte extravasations (Daffertshofer et al 2005, 5 
Hynynen et al 2001). 
Conventional ultrasound pulse shapes and sequences can control the type and magnitude of 
cavitation, but they are inefficient in distributing cavitation in physiological systems (Choi 
and Coussios 2012). In capillary opening, cavitation-induced permeability increases are 
produced as spot-like patterns resulting in an inhomogeneous distribution of a model drug 10 
(Choi et al 2007b, Stieger et al 2007). This spatial inhomogeneity in treatment could be due 
to cavitation activity being poorly distributed throughout the microvasculature. Long PLs 
(>10ms) immobilize flowing MBs upon their entrance into the focal volume due to primary 
radiation forces (Dayton et al 2002), thus constraining their activity to a limited region (Choi 
and Coussios 2012). Typical therapeutic pulses have durations of 10-100ms and pulse 15 
repetition frequencies (PRFs) on the order of Hz (Nhan et al 2013, O’Reilly and Hynynen 
2012, Choi et al 2011a, Hynynen et al 2001), yet the highest magnitude and number of 
cavitation events occur within the first few milliseconds, thus producing an inefficient and 
heterogeneous treatment.  In vivo studies have shown that long PLs lead to heterogeneous 
drug distributions, with molecules being accumulated near large vessels, such as arterioles 20 
and venules (Choi et al 2010). In contrast, short PLs emitted at repetition periods on the 
order of microseconds were shown to enhance the desired in vivo bioeffect without 
compromising safety (O’Reilly et al 2011, Choi et al 2011b). Further complicating the 
ability to control cavitation is that the pressure threshold for inertial cavitation decreases with 
the PL (Radhakrishnan et al 2013, Gruber et al 2014) and thus long PLs promote faster MB 25 
destruction. Additionally, high acoustic pressures and the concomitant inertial cavitation 
events introduce greater spatial bias on the cavitation distribution (Choi and Coussios 2012). 
For clinical applications, conventional ultrasonic pulses could produce over-treated and 
under-treated areas within the same focal volume, resulting in unsafe or inefficient therapies, 
respectively. 30 
The primary aim of the present study is to exploit flow in the design of a new therapeutic 
ultrasonic pulse sequence that will improve acoustic cavitation distribution over time and 
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space, while avoiding or minimising damage-related cavitation activity. We evaluated the use 
of short PLs interspaced throughout a 100ms burst with off-time intervals placed between. 
The use of this novel burst sequence was empirically shown to facilitate improved drug 
delivery distribution in vivo (Choi et al 2011b, 2011a), however there has been no direct 
evidence of improved cavitation distribution. The main assumption is that sonication of a MB 5 
population during flow using our burst sequence would enable MBs to move during the short 
“off” state of the sequence. The distance MBs travel would depend on the time intervals 
between two adjacent pulses and the fluid velocity. During the “on” state, MBs are expected 
to be immobilised after a few cycles due to primary radiation force effects pushing them 
against the tubular (or vascular) wall in the direction of the FUS propagation. If MBs remain 10 
intact during each pulse, the spatial distribution of MB activity could be adjusted solely by 
modifying the idle intervals between FUS pulses. Whereas conventional pulse shapes and 
sequences can control the cavitation type, magnitude and duration, our new burst sequence 
has the additional control of cavitation distribution. 
2. Methods 15 
2.1 MB manufacturing 
In-house manufactured lipid-shelled MBs were prepared and characterized prior to every 
experiment. Three phospholipids (Avanti Polar Lipids Inc., AL, USA), namely 
Dipalmitoylphosphatidylcholine (DPPC-82%), Dipalmitoylphosphatidic acid (DPPA-8%), 
and dipalmitolyphosphatidylethanolamine–PEG5000 (DPPE–PEG5000-10%) were mixed 20 
and diluted with saline and glycerol. Perfluorobutane (FluoroMed L.P., Texas, USA) was 
added and the mixture was then amalgamated. The MB concentration and size distribution 
were measured using a haemocytometer and a microscope following previously described 
protocols (Sennoga et al 2010). The MB concentration was found to be 7.3±4∙109 MBs/ml 
and the mean size 1.62±0.87μm while excluding bubbles with diameters below 0.5μm. In 25 
order to ensure clinical relevance, the MB suspension was diluted to ~ 5∙107 MBs/ml, 
approximately 25x the acceptable dose for clinical applications which is 0.02ml/kg (Unger et 
al 2004) or 2.04∙106 MBs/ml. This calculation was performed for an average male mass of 
70kg with a total blood volume of 5L. 
 30 
 
 
7 
 
2.2 Experimental setup 
Sonication of flowing MBs was performed in an in vitro system at physiologically relevant 
fluid velocities (figure 1). A 300-μm diameter silicone elastomer tube (Saint-Gobain 
Performance Plastics, Paris, France) was submerged and positioned horizontally in a tank 
containing deionised and degassed water. MBs were injected into the tube using a syringe 5 
pump (Instech, Plymouth Meeting, PA, USA) which allowed a constant flow rate of 
43.6μl/min, corresponding to fluid velocity of 10mm/s. This velocity was on the same order 
of magnitude as the peak blood velocity in a medium-sized arteriole of size comparable to 
our tube model (Tangelder et al 1986).  
A 0.5MHz spherical-segment, single-element transducer (active diameter: 64mm, nominal 10 
f-number: 0.98, nominal FWHM: 5.85mm, focal length: 62.6mm, part number: H107; 
Sonic Concepts Inc., Bothel, WA, USA) was used to emit the FUS. The tube was placed 6cm 
away from the transducer’s surface and overlapped its focal point, which was determined 
earlier using a 0.2mm diameter PVDF needle hydrophone (Precision Acoustics Ltd, 
Dorchester, UK). Ultrasound emission and detection was controlled with Matlab (The 15 
Mathworks, Natick, MA, USA). Two function generators (33500B Series, Agilent 
technologies, Santa Clara, CA, USA) were employed for the generation of the various pulse 
shapes/sequences, with the first defining the pulse sequence and the second dictating the 
pulse shape. The signal was amplified by a 50dB power amplifier (Precision Acoustics Ltd, 
Dorchester, UK) and applied to the 0.5MHz transducer via a matching box (Sonic Concepts 20 
Inc., WA, USA). 
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Figure 1. Experimental setup. (a) Two function generators were used to produce distinct pulse shapes and 
sequences emitted by the 0.5MHz FUS transducer. The PCD signal was filtered with a 5MHz high pass filter, 
captured with an oscilloscope and saved to a PC for processing. (b) A syringe pump kept a constant MB flow 
rate within the 300-μm diameter tube. (c) Each pulse of ultrasound was emitted at a specific pulse repetition 5 
frequency for a limited duration specified by a burst length. Each burst was emitted at a specific burst repetition 
frequency. Abbreviations: PRP: peak rarefactional pressure; PL: pulse length; PRF: pulse repetition frequency; 
BL: burst length; BRF: burst repetition frequency. 
MB acoustic response was captured with a 7.5MHz transducer (diameter: 12.7mm, nominal 
f-number: 4.72, focal length: 60mm, part number: U8423589; Olympus Industrial, Essex, 10 
UK) coaxially aligned with the 0.5MHz transducer. In order to avoid signal saturation due to 
reflection and scattering by the tube at the fundamental frequency, the PCD signal was fed 
through a 5-MHz analog high pass filter (fc=5MHz, -20dB at 4MHz, 50Ohm, part number: 
MH-500P-C-P; Allen Avionics, Mineola, NY, USA) and a 28dB preamplifier (Stanford 
Research Systems, Sunnyvale, CA, USA) to an oscilloscope (8-bit, sampling rate 50MSa/s; 15 
Tektronix, Bracknell, UK). The time-domain trace was then saved to a PC for processing. 
2.3 Ultrasound parameters  
The design of efficient pulse sequences was based on optimising specific parameters of the 
emitted ultrasound. Optimisation was performed in terms of spatiotemporal distribution of the 
cavitation energy emissions. Based on previous in vivo results (Choi et al 2011b, 2007a), we 20 
refined the parametric search to a small subset of values (Table 1). As discussed, the 
parameters used differ from conventional pulse sequences in the time scale. Whereas 
conventional pulse repetition periods are on the order of seconds, here the time interval 
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between the pulses is on the order of microseconds and milliseconds (figure 1). Additionally, 
conventional pulse lengths are often circa 100ms. For this reason, a 100ms-long continuous 
wave pulse was used as the control sequence.  
Table 1: Ultrasound parameters 
Peak rarefactional pressure (kPa) 40-366 
Pulse repetition frequency (kHz) 0.62, 1.25, 2.5, 5 1.25, 2.5, 5, 10 
Pulse length (no. of cycles) 5 25 
Burst length (ms) 100 
Burst repetition frequency (Hz) 0.25 
Number of bursts 10 
 5 
Burst length was kept constant for all the experiments (BL=100ms), since we wanted to 
compare the energy emission distribution in various pulse sequences within a defined period 
of ultrasound exposure. Bursts were emitted at a burst repetition frequency (BRF) of 0.25 Hz, 
i.e. every 4 seconds, to allow MB replenishment into the focal volume. Meanwhile, we tested 
pulse lengths of 5 and 25 cycles (10 and 50μs respectively), to ensure that MBs reached their 10 
highest oscillation amplitude and mode of cavitation at a given pressure (Church 2005). For 
each distinct set of parameters, a total of 10 consecutive bursts were emitted.  
2.4 Data analysis 
The collected raw data were processed in Matlab. Analysis was conducted in terms of energy 
emission and spectral content.  15 
2.4.1 Energy analysis 
Cavitation magnitude, duration and distribution were determined by analysing the energy 
emitted by the cavitating MBs. Energy emissions were calculated by integrating the time 
domain signal with respect to time (i.e. integration of the squared voltage vs. time curve). The 
energy values correlate with the PCD’s electrical energy, which is proportional to the 20 
acoustic energy emitted by the MB cavitation activity. For the purpose of this work, “energy” 
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is relevant as a comparative measurement across the sequences rather than as an absolute 
value. 
Furthermore, we corrected the calculated energy values to compensate for the electrical noise 
contribution. The mean noise energy value was calculated in a signal segment where acoustic 
cavitation was absent and then subtracted from the energy value of each point throughout the 5 
100ms duration. Cumulative energy plots were created to characterise the temporal 
distribution of the cavitation emissions. Two distinct times were calculated, t50 and t80, which 
represented the time that energy emissions reached 50% and 80% of the maximum energy. 
Increased time constants inferred longer MB movement, because the presence of flow 
and pulse intervals enables the MB population to move a greater distance along the 10 
longitudinal axis of the tube, thus producing a more uniform cavitation distribution 
along the lateral axis. 
In addition to increased cavitation persistence, the pulse sequence should be able to 
produce a desired magnitude of cavitation, since this has been previously correlated to 
distinct bioeffects such as drug delivery increase (Choi et al 2014, Graham et al 2014), 15 
tissue heating (Jensen et al 2012) or hemolysis (Chen et al 2003). We therefore defined a 
parameter, the acoustic cavitation output, which is calculated as: 
80totalOutput E t   (1) 
Increased levels of this parameter suggest that the pulse sequences efficiently produce 
cavitation of both high magnitude (or mechanical stress through MB-vessel mechanical 20 
interactions) and increased persistence. Cavitation output of the pulse sequences was used as 
an additional comparison metric to assess their potential bioeffect, regarding not only the 
cavitation magnitude but also its spatiotemporal distribution. 
 2.4.2 Spectral analysis 
Acoustic emissions were spectrally analysed to determine the cavitation mode and duration, 25 
both throughout a 100ms burst and across distinct pulses of a burst. For the latter method, 
each pulse was windowed and analysed independently.  
In order to quantify the spectral features, we calculated the Harmonic to Broadband (HtB) 
ratio. A high HtB value would indicate the dominance of harmonic traits while a HtB value 
close to 1 would indicate the dominance of broadband emissions. The frequency domain was 30 
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separated into two spectral regimes: a) the harmonic component, i.e. the region surrounding 
each harmonic peak (
, 0.1H nf MHz , [10,20]n ), and b) the non-harmonic component, i.e. 
the region between the harmonic peaks (
, , 10.1 , 0.1H n H nf MHz f MHz  ). Harmonic 
frequencies are given by 
, 0H nf nf  where 0 0.5f MHz . The spectral energy within the 
harmonic and non-harmonic regions was summed and division of the harmonic value by the 5 
non-harmonic value gave the HtB ratio. In order to compensate for the different 
bandwidth of the two regions (0.2MHz for the harmonic and 0.3MHz for the non-
harmonic), the harmonic energy was weighted by a factor of 3/2, so that equal spectral 
magnitudes for the two regimes would result to a HtB ratio of 1. 
3. Results 10 
3.1 Energy analysis 
MB acoustic emissions were used to calculate the cavitation energy generated during each 
ultrasound burst. As expected, the mean total cavitation energy (averaged across the 10 
consecutive bursts) rose with the PRP (figure 2). The minimum pressure for detecting 
cavitation activity with our system was approximately 100kPa. Any MB activity below this 15 
threshold was not detectable owing to the low signal-to-noise ratio (SNR). The energy of the 
received emissions from pulsed excitation followed a linear trend with increasing pressure in 
all the sequences evaluated, while the continuous wave control reached a plateau after 
250kPa, which was in good agreement with previous studies (Choi and Coussios 2012). 
There was no clear dependence of the PRF on the magnitude of the total burst energy. For the 20 
PL of 5 cycles there was no notable difference between the various PRFs (figure 2(a)), which 
was unexpected if we take into account the different duty cycles or the different number of 
emitted pulses of each sequence. Lower PRFs (i.e. 0.62kHz and 1.25kHz) led to lower burst 
energies for the PL of 25 cycles (figure 2(b)), since a lower number of pulses were emitted 
during the 100ms burst. The 2.5kHz pulse sequence generated higher energy emissions 25 
compared to the other PRFs (for pressures above 200kPa), an effect which was 
previously observed for pulsed sonication (Flynn and Church 1984, Ciaravino et al 1981).  
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Figure 2. Total burst energies (mean±S.D.) for the various pulse sequences as a function of PRP for PL of 5 (a) 
and 25 cycles (b). Averaging was performed across the 10 consecutive bursts. 
 Whereas the total burst energies provided insight into the magnitude of cavitation activity 
within the focal volume, we also sought to characterize the spatiotemporal distribution of this 5 
activity by analysing features of the cumulative energy over time (figure 3). Within a 100ms 
burst sonication, the cumulative energy rose rapidly in the first few milliseconds and then 
plateaued. In nearly all the evaluated sequences, there was no further increase after the first 
40ms, thus indicating a superfluous pulse-on time beyond this point (figure 3(a)). The step-
wise increase depicts the “on” and “off” states of the sonication, with each step’s width 10 
matching the duration of a single pulse. We assumed that slower rise times of the cumulative 
energy are related to improved spatial distribution of cavitation activity since MBs are 
flowing. Following normalisation to the total burst energy, the t50 and t80 constants, or the 
time needed for energy emissions to reach 50% and 80% of the total value, were calculated 
(figure 3(a)). Lower acoustic pressures had higher time constants for both 5 and 25 cycle PLs 15 
and for all PRFs (figures 3(b)-(e)), providing evidence for prolonged cavitation activity. 
Moreover, comparison between 5 (figures 3(b) and 3(d)) and 25 cycles (figures 3(c) and 3(e)) 
revealed consistently higher t50 and t80 values for the shorter PL. Unlike 25-cycle pulses, short 
5-cycle pulses increased and stabilised the t50 and t80 values for higher pressures 
(PRP>200kPa).  It is also evident that lower PRFs (or long pulse repetition periods) led to 20 
higher time constants, since the same number of pulses is emitted in a longer period of time. 
An exception to this trend is a PRF of 0.62kHz which produced lower time constants than 
1.25kHz at low pressures and a PL of 25 cycles (figures 3(c) and 3(e)). This may originate 
from the relatively low achieved SNR in the corresponding time-domain signal and/or 
inefficient noise correction. As previously discussed we excluded values below 100kPa for 25 
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all data sets and data points of PRP=110kPa (PRF=0.62kHz and 1.25kHz) for the PL of 5 
cycles due to low SNR. 
 
Figure 3. Temporal distribution of cavitation activity. (a) Normalised cumulative energy (PRP=147kPa, PL=25 
cycles) with representative t50 and t80 constants. t50 (b,c) and t80 (d,e) values (mean±S.D.) indicate the time until 5 
energy reaches the 50% and the 80% of its maximum value for PL of 5 (b,d-empty symbols) and 25 cycles (c,e-
filled symbols). Averaging was performed across the 10 consecutive bursts.  
Efficient therapeutic pulse sequences should ideally produce an adjustable magnitude of 
uniformly distributed cavitation activity. Quantification of the combination of energy 
emissions with high temporal persistence was achieved with the calculation of the cavitation 10 
output parameter using equation (1). Essentially, cavitation output (figure 4) is derived by 
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multiplying the data from figures 2(a) and 2(b) by the data from figures 3(d) and 3(e) 
respectively. Output was consistently higher for low PRFs for pulses of 5 cycles but there is 
no visible trend across the PRPs (figure 4(a)). In contrast, for the 25 cycles case it is 
maximized within the PRP range of 100-200kPa (figure 4(b)), confining the region where 
both burst energy and acoustic cavitation duration are high enough. It can be deducted that 5 
lower PRPs around the peak of 150kPa are the most suitable candidates for the optimal 25 
cycle pulse sequence (figure 4(b)). Output is larger at higher pressures (circa 225kPa) in the 
continuous wave control. Generally 5-cycle pulses resulted in higher values than 25 cycles, 
which is reasonable if we account for the increased t80 values of the 5-cycle sequences 
(figures 3(d) and 3(e)) and the energy values which are on the same order of magnitude 10 
(figure 2). 
 
Figure 4: Acoustic cavitation output. Output values (mean±S.D.) as a function of PRP for PL of 5 (a) and 25 
cycles (b). Averaging was performed across the 10 consecutive bursts. 
3.2 Spectral analysis 15 
In addition to the analysis of the emitted MB energy, we were interested in identifying the 
cavitation mode through spectral analysis. Fourier Transforms of the PCD signal acquired 
during the entire ultrasound burst had similar structures to one another, presenting peaks at 
the harmonics to the driving frequency (an example is given in figure 5(a) for PRP=147kPa, 
PL=25cycles). The bandwidth of the harmonics was greater for the evaluated pulse sequences 20 
than for the continuous wave control, due to the shorter PL (5 and 25 cycles). Furthermore, 
their magnitude varied with the PRF. The HtB ratio was highest in the region of PRP=100-
200kPa (figure 5(b)), indicating increased dominance of the harmonic element, i.e. higher 
levels of stable cavitation rather than transient and inertial cavitation. Qualitative 
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interpretation of the spectra confirmed that HtB ratios decrease above 200kPa due to the 
ascent of the broadband signal floor, i.e. due to increased levels of transient inertial 
cavitation. 
 
Figure 5. Spectral analysis of the PCD signal acquired during the entire ultrasound burst. a) Magnitude of the 5 
Fourier Transforms for different PRFs (PRP=147kPa, PL=25 cycles). b) Harmonic to Broadband ratio 
(mean±S.D.) vs. PRP for various pulse sequences (PL=25 cycles). Averaging was performed across the 10 
consecutive bursts. 
Pulse-by-pulse analysis revealed the time-resolved cavitation mode (figure 6). At low 
pressures (figure 6(a)) there was no detectable MB activity and at high pressures (figure 6(c)) 10 
short-duration transient cavitation was detected. Moderate pressures maintained cavitation 
activity for a longer period than higher pressures (figure 6(b)) and induced mainly stable 
oscillations which were indicated by the persistence of harmonics and limited presence of 
broadband signal. Traces of transient cavitation during the first pulses of moderate pressures 
were detected (figure 6(b)) which could be attributed to the destruction of resonant MBs. 15 
Quantification of the spectral characteristics of the 25-cycle pulse sequences is given in 
figure 7. Here the time-resolved HtB ratio obtain its maximum values in the pressure region 
of 100-200kPa. Interestingly, with the exception of the 0.62kHz sequence (figure 7(a)), the 
dominance of harmonic over the non-harmonic component persists for approximately 40 
pulses (figures 7(b)-(d)). The broad spectral bandwidth of the short 5-cycle pulse sequences 20 
rendered the accurate quantification of the HtB ratio difficult and thus was not processed 
here. However, it was expected that a similar trend was present in both the 5- and 25-cycle 
cases.  
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Figure 6: Pulse-by-pulse spectral analysis. Magnitude of Fast Fourier Transforms for PRP of 75kPa (a), 147kPa 
(b) and 294kPa (c). PRF=2.5kHz, PL=25cycles. 
 5 
 
Figure 7. Extrapolated contour plots of the pulse-by-pulse HtB ratios for PRFs of 0.62kHz (a), 1.25kHz (b), 2.5 
kHz (c) and 10 kHz (d). PL=25cycles. 
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4. Discussion  
4.1 Acoustic cavitation distribution 
We have demonstrated that the spatiotemporal distribution of acoustic cavitation activity 
seeded by flowing MBs can be adjusted by modifying specific features of an ultrasonic pulse 5 
shape and sequence. Whilst in previous therapeutic approaches high acoustic pressures and 
transient events enhanced the desired bioeffect, e.g. the vascular permeability increase (Nhan 
et al 2013, Choi et al 2011a, O’Reilly and Hynynen 2012, Choi et al 2010, 2007a), herein 
moderate pressures and stable activity of the cavitation nuclei is shown to facilitate longer 
and more uniform cavitation distribution (figure 6). It is known that increased pressures 10 
above the threshold of transient inertial cavitation lead to rapid collapse of MBs and to a 
concomitant high energy output (figure 1), i.e. increased induced shear stress (Caskey et al 
2007). The exerted force in this case is higher but dispersed across the vasculature (Choi et al 
2007b, Stieger et al 2007) and proportional to the MB concentration in the vessel. 
Furthermore, the fast elimination of cavitation nuclei in these pressures (figure 6) reduces 15 
cavitation longevity and necessitates longer pulse repetition periods (on the order of 0.1 to 2 
seconds) to allow MB replenishment in the focal volume (Choi et al 2011a). Previous studies 
have determined the pressure threshold of transient inertial cavitation initiation in the area 
above 250-300kPa, both in high (Radhakrishnan et al 2013) and low (Gruber et al 2014) 
insonation frequencies.  As a result, it can be argued that spatial uniformity can be improved 20 
by sonicating the same MB population with moderate acoustic pressures (<200kPa) and 
increasing their lifetime. Additionally, 5-cycle pulse sequences sustained cavitation for more 
than the longer 25-cycles sequences (figure 3). Thus shorter PLs offer the potential for 
greater lifetime of the flowing MBs, leading to a more uniform distribution of bioeffects 
along a vessel. This effect of short-PL sequences has been previously reported in vivo based 25 
on empirical evidence of BBB disruption (Choi et al 2011b, 2011a). In this paper we have 
confirmed that the reported improvement is directly correlated with the persisting MB-seeded 
acoustic cavitation activity (figures 3,6). 
MB activity was shown to be maintained for approximately 40 pulses in moderate pressures 
for the PL of 25 cycles (figures 6 and 7), implying that the lifetime of MBs at a given 30 
pressure is directly correlated with the number of the experienced cycles. Within the stable 
cavitation regime, i.e. below 200kPa (figure 5), MBs are diminishing in size during each 
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oscillation cycle due to rectified diffusion and dissolution of the encapsulated gas (Borden 
and Longo 2002), leading to a gradual decrease of echogenicity and cavitation activity 
(Radhakrishnan et al 2013). Thus, by defining the number of the emitted ultrasound cycles at 
a specific pressure, one can adjust the longevity of FUS-MBs interactions and control the 
spatiotemporal distribution of acoustic cavitation.   5 
Our method for the distribution characterisation was implemented in vitro while assuming 
that the “idle” period between pulses would result in MB movement, though direct optical 
distance measurements were lacking. MB mobility was thus assessed by the calculated 
temporal constants t50 and t80. The highest t80 values were found to be ~30-35ms (figure 3). 
Assuming that the MB velocity during the pulse-off time is approximately equal to the 10 
average fluid velocity of 10mm/s, then a PRF of 1.25kHz (off-time of 0.75ms) and a PRP 
of 147kPa, which has cavitation activity present for 40 pulses (figure 7), would result in 
individual MBs moving ~0.3mm along the lateral direction. The respective value for the 
continuous wave would be negligible due to primary radiation force effects (Dayton et al 
2002). The pulse interval time scale (~0.1-1ms for the various sequences) allowed inter-pulse 15 
MB movement of several microns (1-10μm) which is comparable with the MB size. It is 
possible that MBs could be “rolling” on the tubular or vascular wall, since these distances are 
on the same order as the MB radii.  Increased t80 values are expected to lead to a more 
homogeneous cavitation distribution and bioeffect through the increased mobility of the 
cavitation nuclei. In our setting, the volume of the MB suspension within the focus is ~ 20 
0.35mm
3. For the clinical dose (2∙106 MBs/ml) and assuming uniform MB distribution 
across the 5mm lateral FWHM, we would have 700MBs over 5mm or 1MB every 7μm. 
If each MB moved more than 7μm (which is the case with most of our pulse sequences), 
the spatial distribution of acoustic cavitation activity would be uniform throughout the 
focal volume. For the in vivo applications, the concept of “mobile” bubbles demonstrated 25 
here could change the cavitation-induced inhomogeneous pattern of permeability increase 
(Nhan et al 2013, Stieger et al 2007) into a more uniform pattern, as shown by Choi et al. 
(2011b, 2011a).  
All the aforementioned calculations are valid only if fast bubble destruction is avoided, i.e. 
for stable cavitation behaviour. It is argued here that stable cavitation is the dominant 30 
cavitation mode below 200kPa (figures 5,6,7). Pressures in the 100-200kPa window present 
equal or higher values of the output parameter (figure 4). Those pulse sequences are therefore 
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equally or more efficient in terms of uniformity of the spatiotemporal acoustic cavitation 
distribution. 
4.2 Limitations of the study 
The findings of the present study were based on the data obtained using a single-element 
PCD. This method is an efficient and inexpensive tool to evaluate cavitation activity, but is 5 
neither able to extract spatial information beyond the focal volume of interrogation nor 
distinguish cavitation activity of regions within the focal volume. The present results thus 
would be further validated by other techniques, such as passive acoustic mapping (PAM), to 
directly assess the spatial distribution of bubble activity (Gyöngy and Coussios 2010), and 
high-speed camera optical observations. Additionally, detectability limits of the PCD method 10 
are correlated with the electronic noise floor. Our temporal constants (figure 3) are thus prone 
to underestimation, since a signal falling below the system’s noise floor could persist for a 
longer period but would not be detected. Another limitation of PCD is that when spectral 
analysis is required, short PLs present an increased mixture of frequency content and 
therefore harmonics are inherently broadened. Consequently it was not possible to spectrally 15 
analyse the data for the 5-cycle pulse sequences as we did for the 25-cycles.  
 Furthermore, the bioeffect of such pulse shapes and sequences has to be estimated in future 
in vivo experiments. It is uncertain whether our pulse shapes and sequences will have an 
equally efficient in vivo bioeffect when compared with the existing ones. Our relatively 
simple physiologically relevant tube model provided insight about the effect of the various 20 
pulse sequences on the flowing bubbles cavitation dynamics. However, the real vasculature 
cannot be correctly approximated in vitro. A diverse range of parameters, such as vessel 
diameters and orientations, flow rates and acoustic pressure local inhomogeneity due to the 
interaction with the tissues are likely to affect the spatiotemporal distribution of cavitation 
dynamics. Vessel size for example is shown to affect the MB activity, especially in small-size 25 
vessels like the capillaries where the vessel wall directly influences the MB oscillation 
boundary conditions (Chen et al 2012, Caskey et al 2007). Additionally, water is not the ideal 
tissue-mimicking material since its acoustic properties significantly differ from the respective 
values of the tissues. Future studies are planned to be carried out in agar phantom models, in 
an effort to increase physiological relevance and adequately mimic in vivo conditions. 30 
Another source of bias is related with the MB concentration in each of the experiments. 
Whereas every effort was made to avoid concentration variations, it is likely that there were 
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temporal fluctuation in the concentration of the sonicated MBs. Such fluctuation may be 
responsible for the unexpected results in the total emitted energy (figure 2) or the temporal 
constants of each sequence (figure 3). Finally, in vivo blood flow rates vary considerably, 
whereas in our proof-of-principle study only one set flow rate was used. To reinforce our 
findings regarding MB mobility, the effect of various flow rates will be investigated in future 5 
experiments using PAM. Nevertheless, our simple in vitro model can prove useful in creating 
safe and efficient ultrasound pulse sequences for use in every kind of therapeutic application.    
4.3 Clinical relevance  
Low power and short-PL sequences can be used for a wide range of clinical applications such 
as capillary opening techniques for targeted drug delivery, sonothrombolysis, and 10 
sonoporation. Short PLs with low amplitude offer the advantage of limited interference, 
reduced standing-wave formation and negligible thermal effects. Particularly for FUS-based 
therapies in the brain, the formation of standing waves within the skull is expected to be 
avoided when employing short PL therapeutic pulses. Furthermore, the focal volume can be 
more accurately defined since skull-specific aberrations and sidelobe magnitude could be 15 
easily ignored for short-PL sonication (Jones et al 2013, O’Reilly et al 2014). We have 
shown here that cavitation output for short 5-cycle pulse shapes is similar to longer 25-cycles 
shapes (figure 4). It is therefore expected that a shorter pulse is likely to have a similar 
bioeffect in the BBB disruption, as shown before (Choi et al 2011b, 2011a). Furthermore, it 
has been shown in vivo that single-cycle sonication at repetition periods similar to the 20 
present work can produce BBB disruption and successful drug delivery into the brain 
(O’Reilly et al 2011). Additionally, the spatial distribution of the drug concentration was 
found to be more uniform within the focal volume for sonication with short-PL and 
high PRF (Choi et al 2011b). The aforementioned in vivo studies reported the 
macroscopic bioeffects produced by short-PL sonication and in this work we provided a 25 
microscopic explanation based on MB mobility during the pulse off-time. 
 Sonothrombolysis is also likely to be favoured by the time-resolved cavitation activity of the 
flowing MBs. With known size and location of a thrombus in a vessel, our pulse sequences 
could be used to uniformly treat the entire pathology. The time constants found here (figure 
3) could be employed to calculate the proper PL and inter-pulse interval that would allow 30 
MBs to travel and acoustically treat the whole length of the thrombus before reaching their 
fragmentation point. Furthermore, the proper selection of the acoustic pressure and the 
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relative cavitation output (figures 2 and 4) could provide efficient and safe therapy, 
minimising damage-related high-amplitude inertial cavitation. Similar ideas and 
methodologies can be applied in other MB-mediated therapeutic applications. 
5. Conclusion 
In conclusion, we were able to incorporate the presence of flow in the control of the 5 
spatiotemporal distribution of acoustic cavitation activity by creating and testing new 
therapeutic pulse sequences, comprising of pulse trains with μs pulse intervals. Stable 
cavitation with high acoustic cavitation output and increased persistence was noticed at 
pressures below 200kPa and for longer time intervals between the pulses. Shorter PLs 
allowed longer acoustic cavitation activity and MB mobility, favoured improved temporal 10 
distribution and presented increased acoustic output values. Low-power short-pulse 
sequences can thus uniformly distribute the MB-seeded acoustic cavitation activity and 
provide safe, efficient and homogenous treatment in a wide range of pathologies. Future work 
involves the investigation of the effect of flow rates and vessel diameters on the present pulse 
sequences efficacy. Finally, PAM will be used to determine the spatial distribution of 15 
acoustic cavitation activity.  
Acknowledgements 
The authors wish to acknowledge Dr. T. Matsunaga for the guidelines and discussions in the 
MB manufacturing process. Additionally, the authors wish to thank Dr. Mengxing Tang 
and Dr. Robert Eckersley for fruitful discussions and Mr. Gary Jones for building the 20 
experimental apparatuses. This work was funded by the Royal Society Research Grant 
2014 (RG130795). A.N.P. wishes to thank the Bodossakis foundation for financial support 
during this study. 
The authors declare no conflict of interest regarding the aims or results of the present paper.  
  25 
22 
 
References 
Apfel R 1997 Sonic effervescence: A tutorial on acoustic cavitation J. Acoust. Soc. Am. 101 1227–37 
Apfel R E and Holland C K 1991 Gauging the likelihood of cavitation from short-pulse, low-duty cycle 
diagnostic ultrasound. Ultrasound Med. Biol. 17 179–85 
Baseri B, Choi J J, Tung Y-S and Konofagou E E 2010 Multi-modality safety assessment of blood-brain barrier 5 
opening using focused ultrasound and definity microbubbles: a short-term study. Ultrasound Med. Biol. 
36 1445–59 
Borden M A and Longo M L 2002 Dissolution Behavior of Lipid Monolayer-Coated, Air-Filled 
Microbubbles:  Effect of Lipid Hydrophobic Chain Length Langmuir 18 9225–33 
Caskey C F, Stieger S M, Qin S, Dayton P a and Ferrara K W 2007 Direct observations of ultrasound 10 
microbubble contrast agent interaction with the microvessel wall. J. Acoust. Soc. Am. 122 1191–200 
Chen H, Brayman A a and Matula T J 2012 Characteristic microvessel relaxation timescales associated with 
ultrasound-activated microbubbles. Appl. Phys. Lett. 101 163704 
Chen W-S, Brayman A A, Matula T J and Crum L A 2003 Inertial cavitation dose and hemolysis produced in 
vitro with or without Optison. Ultrasound Med. Biol. 29 725–37 15 
Choi J and Coussios C 2012 Spatiotemporal evolution of cavitation dynamics exhibited by flowing 
microbubbles during ultrasound exposure J. Acoust. Soc. Am. 132 
Choi J J, Carlisle R C, Coviello C, Seymour L and Coussios C-C 2014 Non-invasive and real-time passive 
acoustic mapping of ultrasound-mediated drug delivery. Phys. Med. Biol. 59 4861–77 
Choi J J, Pernot M, Small S a and Konofagou E E 2007a Noninvasive, transcranial and localized opening of the 20 
blood-brain barrier using focused ultrasound in mice. Ultrasound Med. Biol. 33 95–104 
Choi J J, Selert K, Gao Z, Samiotaki G, Baseri B and Konofagou E E 2011a Noninvasive and localized blood-
brain barrier disruption using focused ultrasound can be achieved at short pulse lengths and low pulse 
repetition frequencies. J. Cereb. Blood Flow Metab. 31 725–37 
Choi J J, Selert K, Vlachos F, Wong A and Konofagou E E 2011b Noninvasive and localized neuronal delivery 25 
using short ultrasonic pulses and microbubbles. Proc. Natl. Acad. Sci. U. S. A. 108 16539–44 
Choi J J, Wang S, Tung Y-S, Morrison B and Konofagou E E 2010 Molecules of various pharmacologically-
relevant sizes can cross the ultrasound-induced blood-brain barrier opening in vivo. Ultrasound Med. Biol. 
36 58–67 
Choi J, Pernot M, Brown T R, Small S a and Konofagou E E 2007b Spatio-temporal analysis of molecular 30 
delivery through the blood-brain barrier using focused ultrasound. Phys. Med. Biol. 52 5509–30 
Chomas J E, Dayton P, May D and Ferrara K 2001 Threshold of fragmentation for ultrasonic contrast agents. J. 
Biomed. Opt. 6 141–50 
Church C C 2005 Frequency, pulse length, and the mechanical index Acoust. Res. Lett. Online 6 162 
Church C and Carstensen E 2001 “Stable” inertial cavitation Ultrasound Med. Biol. 27 1435–7 35 
Ciaravino V, Flynn H G and Miller M W 1981 Pulsed enhancement of acoustic cavitation: A postulated model 
Ultrasound Med. Biol. 7 159–66 
23 
 
Daffertshofer M, Gass A, Ringleb P, Sitzer M, Sliwka U, Els T, Sedlaczek O, Koroshetz W J and Hennerici M 
G 2005 Transcranial low-frequency ultrasound-mediated thrombolysis in brain ischemia: increased risk of 
hemorrhage with combined ultrasound and tissue plasminogen activator: results of a phase II clinical trial. 
Stroke. 36 1441–6 
Dayton P a., Allen J S and Ferrara K W 2002 The magnitude of radiation force on ultrasound contrast agents J. 5 
Acoust. Soc. Am. 112 2183 
Dayton P, Morgan K, Klibanov A, Brandenburger G, Nightingale K and Ferrara K 1997 A preliminary 
evaluation of the effects of primary and secondary radiation forces on acoustic contrast agents IEEE 
Trans. Ultrason. Ferroelectr. Freq. Control 44 1264–77 
Deelman L E, Declèves A-E, Rychak J J and Sharma K 2010 Targeted renal therapies through microbubbles and 10 
ultrasound. Adv. Drug Deliv. Rev. 62 1369–77 
Ferrara K, Pollard R and Borden M 2007 Ultrasound microbubble contrast agents: fundamentals and application 
to gene and drug delivery. Annu. Rev. Biomed. Eng. 9 415–47 
Fischer K, McDannold N and Zhang Y 2009 Renal ultrafiltration changes induced by focused US Radiology 
253 697–705 15 
Flynn H G and Church C C 1984 A mechanism for the generation of cavitation maxima by pulsed ultrasound. J. 
Acoust. Soc. Am. 76 505–12 
Graham S M, Carlisle R, Choi J J, Stevenson M, Shah A R, Myers R S, Fisher K, Peregrino M, Seymour L and 
Coussios C C 2014 Inertial cavitation to non-invasively trigger and monitor intratumoral release of drug 
from intravenously delivered liposomes J. Control. Release 178 101–7 20 
Gruber M J, Bader K B and Holland C K 2014 Cavitation thresholds of contrast agents in an in vitro human clot 
model exposed to 120-kHz ultrasound J. Acoust. Soc. Am. 135 646–53 
Gyöngy M and Coussios C-C 2010 Passive cavitation mapping for localization and tracking of bubble 
dynamics. J. Acoust. Soc. Am. 128 EL175–80 
Hosseinkhah N, Chen H, Matula T J, Burns P N and Hynynen K 2013 Mechanisms of microbubble-vessel 25 
interactions and induced stresses: a numerical study. J. Acoust. Soc. Am. 134 1875–85 
Hosseinkhah N and Hynynen K 2012 A three-dimensional model of an ultrasound contrast agent gas bubble and 
its mechanical effects on microvessels. Phys. Med. Biol. 57 785–808 
Hynynen K, McDannold N, Vykhodtseva N and Jolesz F 2001 Noninvasive MR Imaging–guided Focal 
Opening of the Blood-Brain Barrier in Rabbits 1 Radiology 220 30 
Jensen C R, Ritchie R W, Gyöngy M, Collin J R T, Leslie T and Coussios C-C 2012 Spatiotemporal monitoring 
of high-intensity focused ultrasound therapy with passive acoustic mapping. Radiology 262 252–61 
Jones R M, O’Reilly M a and Hynynen K 2013 Transcranial passive acoustic mapping with hemispherical 
sparse arrays using CT-based skull-specific aberration corrections: a simulation study. Phys. Med. Biol. 58 
4981–5005 35 
Konofagou E E 2012 Optimization of the ultrasound-induced blood-brain barrier opening. Theranostics 2 1223–
37 
Lauterborn W 1976 Numerical investigation of nonlinear oscillations of gas bubbles in liquids J. Acoust. Soc. 
Am. 59 283 
24 
 
Li P, Gao Y, Zhang J, Liu Z, Tan K, Hua X and Gong J 2013 Renal interstitial permeability changes induced by 
microbubble-enhanced diagnostic ultrasound. J. Drug Target. 21 507–14 
Liu Y, Yi S, Zhang J, Fang Z, Zhou F, Jia W, Liu Z and Ye G 2013 Effect of microbubble-enhanced ultrasound 
on prostate permeability: a potential therapeutic method for prostate disease. Urology 81 921.e1–7 
Marmottant P, van der Meer S, Emmer M, Versluis M, de Jong N, Hilgenfeldt S and Lohse D 2005 A model for 5 
large amplitude oscillations of coated bubbles accounting for buckling and rupture J. Acoust. Soc. Am. 118 
3499 
Nhan T, Burgess A, Cho E E, Stefanovic B, Lilge L and Hynynen K 2013 Drug delivery to the brain by focused 
ultrasound induced blood-brain barrier disruption: Quantitative evaluation of enhanced permeability of 
cerebral vasculature using two-photon microscopy. J. Control. Release 172 274–80 10 
O’Reilly M A, Jones R and Hynynen K 2014 Three-Dimensional Transcranial Ultrasound Imaging of 
Microbubble Clouds Using a Sparse Hemispherical Array IEEE Trans. Biomed. Eng. 61 1285–94 
O’Reilly M a., Waspe A C, Ganguly M and Hynynen K 2011 Focused-Ultrasound Disruption of the Blood-
Brain Barrier Using Closely-Timed Short Pulses: Influence of Sonication Parameters and Injection Rate 
Ultrasound Med. Biol. 37 587–94 15 
O’Reilly M and Hynynen K 2012 Blood-Brain Barrier: Real-time Feedback-controlled Focused Ultrasound 
Disruption by Using an Acoustic Emissions–based Controller Radiology 263 
Palanchon P, Tortoli P, Versluis M and de Jong N 2005 Optical observations of acoustical radiation force effects 
on individual air bubbles IEEE Trans. Ultrason. Ferroelectr. Freq. Control 52 104–10 
Qin S and Ferrara K W 2006 Acoustic response of compliable microvessels containing ultrasound contrast 20 
agents. Phys. Med. Biol. 51 5065–88 
Radhakrishnan K, Bader K B, Haworth K J, Kopechek J a, Raymond J L, Huang S-L, McPherson D D and 
Holland C K 2013 Relationship between cavitation and loss of echogenicity from ultrasound contrast 
agents. Phys. Med. Biol. 58 6541–63 
De Saint Victor M, Crake C, Coussios C-C and Stride E 2014 Properties, characteristics and applications of 25 
microbubbles for sonothrombolysis. Expert Opin. Drug Deliv. 11 187–209 
Sennoga C a, Mahue V, Loughran J, Casey J, Seddon J M, Tang M and Eckersley R J 2010 On sizing and 
counting of microbubbles using optical microscopy. Ultrasound Med. Biol. 36 2093–6 
Stieger S, Caskey C and Adamson R 2007 Enhancement of Vascular Permeability with Low-Frequency 
Contrast-enhanced Ultrasound in the Chorioallantoic Membrane Model Radiology 243 30 
Stride E P and Coussios C C 2010 Cavitation and contrast: the use of bubbles in ultrasound imaging and therapy 
Proc. Inst. Mech. Eng. Part H J. Eng. Med. 224 171–91 
Tangelder G J, Slaaf D W, Muijtjens a. M, Arts T, oude Egbrink M G and Reneman R S 1986 Velocity profiles 
of blood platelets and red blood cells flowing in arterioles of the rabbit mesentery Circ. Res. 59 505–14 
Tung Y-S, Vlachos F, Choi J J, Deffieux T, Selert K and Konofagou E E 2010 In vivo transcranial cavitation 35 
threshold detection during ultrasound-induced blood-brain barrier opening in mice. Phys. Med. Biol. 55 
6141–55 
Unger E C, Porter T, Culp W, Labell R, Matsunaga T and Zutshi R 2004 Therapeutic applications of lipid-
coated microbubbles. Adv. Drug Deliv. Rev. 56 1291–314 
25 
 
Vlachos F, Tung Y-S and Konofagou E 2011 Permeability dependence study of the focused ultrasound-induced 
blood-brain barrier opening at distinct pressures and microbubble diameters using DCE-MRI. Magn. 
Reson. Med. 66 821–30 
Wang G, Zhuo Z, Xia H, Zhang Y, He Y, Tan W and Gao Y 2013 Investigation into the impact of diagnostic 
ultrasound with microbubbles on the capillary permeability of rat hepatomas. Ultrasound Med. Biol. 39 5 
628–37 
Wang S, Samiotaki G, Olumolade O, Feshitan J a and Konofagou E E 2014 Microbubble type and distribution 
dependence of focused ultrasound-induced blood-brain barrier opening. Ultrasound Med. Biol. 40 130–7 
Yu H and Xu L 2014 Cell experimental studies on sonoporation: State of the art and remaining problems J. 
Control. Release 174 151–60 10 
Zlokovic B V 2008 The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 57 178–
201 
 
 
 15 
